Drug:
Reaction: GAIT DISTURBANCE
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25138979 |
CA |
69 | 1 |
Neuropathy peripheral, Gait disturbance, Gamma-glutamyltransferase abnormal, Blood alkaline phosphatase abnormal, |
||||
OBETICHOLIC ACID, |
||||
| 2 | 25139702 |
GB |
32 | |
Type 2 diabetes mellitus, Myocardial infarction, Impaired gastric emptying, Nerve injury, Eye swelling, Eye haemorrhage, Visual impairment, Illness, Dysstasia, Gait disturbance, Disturbance in attention, Sleep disorder, Diarrhoea, Vomiting, Depressed mood, Suicidal ideation, Anxiety, Eating disorder, |
||||
OLANZAPINE, |
||||
| 3 | 25140038 |
US |
2 | |
Gait disturbance, |
||||
TROFINETIDE, |
||||
| 4 | 25140159 |
US |
73 | 2 |
Gait disturbance, Arthralgia, Paraesthesia, Burning sensation, |
||||
AVACOPAN, PREDNISONE, PREDNISONE, EZETIMIBE, DAPAGLIFLOZIN, LACOSAMIDE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, PITAVASTATIN CALCIUM, CALCIUM, FISH OIL, |
||||
| 5 | 25140443 |
DE |
70 | 2 |
Gait disturbance, Reactive gastropathy, Microscopic enteritis, Neuralgia, Condition aggravated, Off label use, |
||||
CARBAMAZEPINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, OXCARBAZEPINE, |
||||
| 6 | 25140556 |
US |
50 | 2 |
Pain in extremity, Gait disturbance, |
||||
ABATACEPT, |
||||
| 7 | 25140604 |
US |
72 | 2 |
Pneumonia, COVID-19, Gait disturbance, Off label use, |
||||
LEVOKETOCONAZOLE, |
||||
| 8 | 25140672 |
US |
60 | 1 |
Loss of consciousness, Dehydration, Diarrhoea, Vomiting, Muscle spasms, Gait disturbance, Nausea, Diarrhoea, Vomiting, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, DAPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 9 | 25140863 |
US |
1 | |
Dystonia, Gait disturbance, Speech disorder, Dysphonia, Fall, Weight increased, Vision blurred, Chest pain, Dysphagia, Constipation, Pollakiuria, Joint swelling, Myalgia, Dry skin, Depression, Dysarthria, Muscle rigidity, Posture abnormal, Scoliosis, Reduced facial expression, Bradykinesia, Loss of personal independence in daily activities, On and off phenomenon, Weight decreased, Anxiety, Insomnia, Dyskinesia, |
||||
OPICAPONE, EPINEPHRINE, ADRENALINUM, LEVODOPA, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, PRAMIPEXOLE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, POLYETHYLENE GLYCOL 3350, |
||||
| 10 | 25140971 |
80 | 1 | |
Off label use, Hereditary ataxia, Condition aggravated, General physical health deterioration, Fall, Gait disturbance, Dysphonia, |
||||
DALFAMPRIDINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, VALSARTAN, FUROSEMIDE, CARVEDILOL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 11 | 25141015 |
US |
69 | 2 |
Derealisation, Poisoning, General physical health deterioration, Movement disorder, Illness, Visual impairment, Gait disturbance, Pain, Crying, Burning sensation, Hepatic enzyme abnormal, Suspected counterfeit product, Expired product administered, Product use in unapproved indication, |
||||
TINIDAZOLE, |
||||
| 12 | 25141260 |
CA |
27 | |
Optic neuritis, Gait disturbance, Condition aggravated, |
||||
OFATUMUMAB, |
||||
| 13 | 25141386 |
US |
63 | 1 |
Spinal operation, Radiculopathy, Gait disturbance, Pain, |
||||
TOFACITINIB, |
||||
| 14 | 25142100 |
US |
||
Headache, Epistaxis, Tinnitus, Abdominal pain, Balance disorder, Gait disturbance, Pain in extremity, Pollakiuria, Product substitution issue, |
||||
AMLODIPINE BESYLATE, |
||||
| 15 | 25142104 |
JP |
||
Spinal stenosis, Hypoaesthesia, Gait disturbance, Incontinence, |
||||
| 16 | 25142178 |
US |
83 | 2 |
Pain in extremity, Peripheral swelling, Gait disturbance, Ligament sprain, X-ray limb abnormal, |
||||
TAFAMIDIS, ROSUVASTATIN, ATORVASTATIN CALCIUM, APIXABAN, |
||||
| 17 | 25142248 |
US |
55 | 2 |
Gait disturbance, Hypoacusis, |
||||
TOFACITINIB, |
||||
| 18 | 25142324 |
US |
71 | 2 |
Drug ineffective, Epistaxis, Condition aggravated, Gait disturbance, |
||||
TOFACITINIB, |
||||
| 19 | 25142473 |
DE |
70 | 2 |
Weight increased, Fluid retention, Myalgia, Arthralgia, Muscle spasms, Confusional state, Peripheral swelling, Gait disturbance, |
||||
EDOXABAN TOSYLATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, |
||||
| 20 | 25142720 |
US |
||
Gait disturbance, Pain in extremity, |
||||
PEGVALIASE-PQPZ, |
||||
| 21 | 25142762 |
PA |
2 | |
Monoplegia, Gait disturbance, Pain in extremity, |
||||
FULVESTRANT, RIBOCICLIB, |
||||
| 22 | 25142818 |
JP |
||
Motor neurone disease, Muscle disorder, Gait disturbance, |
||||
CABOTEGRAVIR SODIUM, |
||||
| 23 | 25142871 |
US |
72 | 2 |
Osteoarthritis, Gait disturbance, |
||||
RISANKIZUMAB-RZAA, |
||||
| 24 | 25146380 |
|||
Drug ineffective, Product use issue, Withdrawal syndrome, Feeling drunk, Gait disturbance, |
||||
AMANTADINE, |
||||
| 25 | 25138377 |
US |
2 | |
Mobility decreased, Gait disturbance, Influenza, |
||||
SARILUMAB, BISOPROLOL FUMARATE, CILOSTAZOL, GABAPENTIN, HYDROXYCHLOROQUINE, INSULIN GLARGINE, MEMANTINE, MEMANTINE HYDROCHLORIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PREDNISONE, |
||||
| 26 | 25138624 |
CA |
67 | 2 |
Full blood count decreased, Drug level increased, Gait disturbance, Brain fog, |
||||
VENETOCLAX, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOPROLOL, PANTOPRAZOLE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, AZACITIDINE, AZACITIDINE FOR, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 27 | 25138637 |
US |
67 | 1 |
Viral infection, Syncope, Gait disturbance, |
||||
POMALIDOMIDE, CARFILZOMIB, ACYCLOVIR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FOLIC ACID, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 28 | 25140944 |
51 | 2 | |
Bladder pain, Renal pain, Vomiting, Thinking abnormal, Feeling abnormal, Anxiety, Agitation, Gait disturbance, Disturbance in attention, Visual impairment, Vision blurred, Arthralgia, Fatigue, Asthenia, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, DIAZEPAM, LEVOTHYROXINE, |
||||
| 29 | 25137324 |
US |
72 | 1 |
Pneumonia, Drug ineffective, Dyskinesia, Speech disorder, Gait disturbance, |
||||
DEUTETRABENAZINE, DIVALPROEX SODIUM, ALFUZOSIN HYDROCHLORIDE, FINASTERIDE, MELATONIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, QUETIAPINE FUMARATE, QUETIAPINE, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, ERGOCALCIFEROL, AMLODIPINE BESYLATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, DAPAGLIFLOZIN, HYDROXYZINE, LEVOTHYROXINE, LISINOPRIL, |
||||
| 30 | 25137845 |
US |
68 | |
Product use issue, Gait disturbance, Dyspnoea, Device use issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 31 | 25137966 |
US |
81 | 2 |
Dyspnoea, Dizziness, Headache, Vision blurred, Gait disturbance, |
||||
EMPAGLIFLOZIN, MELATONIN, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, APIXABAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, SILDENAFIL CITRATE, SILDENAFIL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ALBUTEROL SULFATE, ALLOPURINOL, BUMETANIDE, OXYGEN, 0XYGEN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LIOTHYRONINE SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DAPAGLIFLOZIN, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
| 32 | 25138053 |
GR |
72 | 2 |
Gait disturbance, Administration site pain, Hypoaesthesia, Muscle spasms, Pain in extremity, Burning sensation, Hypersensitivity, |
||||
| 33 | 25140816 |
83 | 1 | |
Hypotension, Weight decreased, Sepsis, Pneumonia aspiration, Acute respiratory failure, Respiratory failure, Acute kidney injury, Urinary tract infection, Pseudomonas infection, Blood culture positive, Laboratory test interference, Staphylococcal infection, Skin disorder, Dysphagia, Malnutrition, Hypophagia, Dysarthria, Headache, Neck pain, Facial paralysis, Gait disturbance, Cerebrovascular accident, Inappropriate schedule of product administration, |
||||
PEMBROLIZUMAB, |
||||
| 34 | 25141479 |
35 | 2 | |
Arthritis, Injection site reaction, Injection site swelling, Injection site erythema, Injection site induration, Urticaria, Alopecia, Gait disturbance, |
||||
IXEKIZUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LEVOTHYROXINE, CELECOXIB, ERGOCALCIFEROL, MAGNESIUM, |
||||
| 35 | 25132174 |
US |
2 | |
Arthralgia, Back pain, Gait disturbance, Myalgia, Headache, |
||||
EVOLOCUMAB, |
||||
| 36 | 25132425 |
US |
2 | |
Prescribed underdose, Gait disturbance, |
||||
NATALIZUMAB, NATALIZUMAB, |
||||
| 37 | 25132505 |
US |
||
Pain, Arthralgia, Hip arthroplasty, Injection site mass, Lipohypertrophy, Skin mass, Incorrect dose administered, Weight increased, Musculoskeletal stiffness, Gait disturbance, |
||||
FULVESTRANT, FULVESTRANT, |
||||
| 38 | 25132999 |
US |
67 | 2 |
Gait disturbance, Injection site rash, Injection site pain, Injection site irritation, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 39 | 25133244 |
HU |
2 | |
Loss of consciousness, Speech disorder, Confusional state, Gait disturbance, |
||||
OCRELIZUMAB, |
||||
| 40 | 25133551 |
CA |
||
White blood cell count increased, Rheumatic fever, X-ray abnormal, Lung disorder, Laryngitis, Grip strength, Pneumonia, Visual impairment, Stomatitis, Weight increased, Joint range of motion decreased, Bone erosion, Irritable bowel syndrome, Lupus-like syndrome, Systemic lupus erythematosus, Muscle injury, Impaired healing, Dyspnoea, Hepatic enzyme increased, Abdominal pain upper, Headache, Oedema, Loss of personal independence in daily activities, Dizziness, Night sweats, Weight fluctuation, Swollen joint count increased, Pancreatitis, Rectal haemorrhage, Rheumatoid arthritis, Decreased appetite, Obesity, Laboratory test abnormal, Weight decreased, Diarrhoea, Gait disturbance, Glossodynia, Hand deformity, Exostosis, Mobility decreased, Liver disorder, Musculoskeletal stiffness, Sciatica, General physical health deterioration, Adjustment disorder with depressed mood, Depression, Arthritis, Facet joint syndrome, Insomnia, Lip dry, Vomiting, Discomfort, Hepatic cirrhosis, Folliculitis, Inflammation, Pyrexia, Liver injury, Autoimmune disorder, Anti-cyclic citrullinated peptide antibody positive, Peripheral swelling, Oedema peripheral, Pain, Fibromyalgia, Wound, Hypoaesthesia, Condition aggravated, Gastrointestinal disorder, Nasopharyngitis, Feeling hot, Memory impairment, Delirium, Swollen joint count, Breast cancer stage III, Asthma, Porphyria acute, Paraesthesia, Foot deformity, Wheezing, Synovitis, Ill-defined disorder, Arthralgia, Dry mouth, Crohn^s disease, Muscle spasms, Muscular weakness, Rash, Chest pain, Contusion, Infusion related reaction, Peripheral venous disease, Rheumatoid factor positive, Duodenal ulcer perforation, Migraine, Abdominal discomfort, Hypertension, Osteoarthritis, Sinusitis, Pruritus, Grip strength decreased, Asthenia, Type 2 diabetes mellitus, Fatigue, Musculoskeletal pain, Sleep disorder due to general medical condition, insomnia type, Pemphigus, Sleep disorder due to a general medical condition, Abdominal pain, Pulmonary fibrosis, C-reactive protein abnormal, Blood cholesterol increased, Hypersensitivity, Nausea, Joint swelling, Arthropathy, Swelling, Blister, Walking aid user, Drug hypersensitivity, Amnesia, Retinitis, Bursitis, Osteoporosis, Anxiety, Dyspepsia, Frequent bowel movements, Urticaria, Hypercholesterolaemia, Injury, Colitis ulcerative, Psoriatic arthropathy, Malaise, Lupus vulgaris, Confusional state, Dislocation of vertebra, Road traffic accident, Alopecia, Pericarditis, Infection, Ear infection, Lower respiratory tract infection, Wound infection, Helicobacter infection, Maternal exposure during pregnancy, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, SECUKINUMAB, SECUKINUMAB, RAMIPRIL, LISINOPRIL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ERYTHROMYCIN, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ALBUTEROL SULFATE, ALBUTEROL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, HYDROXYCHLOROQUINE SULFATE, LANSOPRAZOLE, ERGOCALCIFEROL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, TOCILIZUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, APREMILAST, APREMILAST, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, PREGABALIN, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PREGABALIN, HYALURONIDASE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, LEFLUNOMIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DESOXIMETASONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LORAZEPAM, FLUOROMETHOLONE, SULFASALAZINE, SULFASALAZINE, QUETIAPINE FUMARATE, QUETIAPINE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, MESALAMINE, TOFACITINIB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LISINOPRIL, RITUXIMAB, RITUXIMAB, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, CAFFEINE, MELOXICAM, MORPHINE, MAGNESIUM, USTEKINUMAB, TOFACITINIB, TOFACITINIB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, LANSOPRAZOLE, INFLIXIMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, CALCIUM CARBONATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, SECUKINUMAB, |
||||
| 41 | 25133960 |
US |
2 | |
Myalgia, Gait disturbance, Hypersensitivity, |
||||
DUPILUMAB, VITAMIN C, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, SERTRALINE HYDROCHLORIDE, |
||||
| 42 | 25134402 |
GB |
||
Eye pain, Lymphadenopathy, Myalgia, Lethargy, Atrial fibrillation, Urticaria, Rash, Headache, Muscle spasms, Pain, Pain in extremity, Pain in extremity, Gait disturbance, Chills, |
||||
ADALIMUMAB, AMLODIPINE, RAMIPRIL, |
||||
| 43 | 25134569 |
US |
79 | 2 |
Vulvovaginal pain, Gait disturbance, Eating disorder, Vulvovaginal burning sensation, Swelling, Abdominal pain, Pruritus, Product use in unapproved indication, |
||||
NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 44 | 25134688 |
US |
69 | 2 |
Gait disturbance, Corneal cyst, Eye infection, Eye pain, Product dose omission issue, Blood glucose decreased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 45 | 25134812 |
US |
2 | |
Joint swelling, Gait disturbance, |
||||
SECUKINUMAB, |
||||
| 46 | 25134940 |
US |
2 | |
Hallucination, Vomiting, Gait disturbance, Confusional state, Constipation, Nausea, Product use in unapproved indication, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 47 | 25135366 |
DE |
53 | 2 |
Suicidal ideation, Gait disturbance, Brain fog, Nausea, Somnolence, Anxiety, Depression, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 48 | 25136304 |
US |
29 | 1 |
Malnutrition, Abdominal pain upper, Gait disturbance, Weight decreased, Fatigue, Stress, Gastric ulcer, |
||||
ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, IRON, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, FISH OIL, |
||||
| 49 | 25136315 |
IT |
78 | 1 |
Ascites, Jaundice cholestatic, Drug-induced liver injury, Gait disturbance, Muscular weakness, |
||||
SOTORASIB, |
||||
| 50 | 25136450 |
US |
1 | |
Product dose omission issue, Gait disturbance, Swelling, |
||||
SECUKINUMAB, |
||||
| 51 | 25136513 |
CA |
2 | |
Abortion induced, Fatigue, Gait disturbance, Maternal exposure during pregnancy, |
||||
RISANKIZUMAB-RZAA, |
||||
| 52 | 25136600 |
US |
32 | 1 |
Toxicity to various agents, Drug abuse, Drug diversion, Dysarthria, Miosis, Gait disturbance, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROCODONE BITARTRATE, BUPRENORPHINE, ALPRAZOLAM, |
||||
| 53 | 25136607 |
US |
78 | 2 |
Gait disturbance, |
||||
LENALIDOMIDE, |
||||
| 54 | 25136777 |
US |
||
Pyrexia, Gait disturbance, Weight bearing difficulty, Arthralgia, |
||||
RAVULIZUMAB, |
||||
| 55 | 25136883 |
US |
1 | |
Drug hypersensitivity, Gait disturbance, Fatigue, Pyrexia, Product use issue, |
||||
PEMBROLIZUMAB, LENVATINIB, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, EVEROLIMUS, EVEROLIMUS TABLETS, VALSARTAN, AMLODIPINE BESYLATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, APIXABAN, LEVETIRACETAM, |
||||
| 56 | 25136897 |
US |
1 | |
Pain in extremity, Gait disturbance, |
||||
INCLISIRAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LOSARTAN, |
||||
| 57 | 25136925 |
US |
71 | 1 |
Prostate cancer, Incorrect product administration duration, Dyspnoea, Fatigue, Gait disturbance, |
||||
PEMBROLIZUMAB, |
||||
| 58 | 25136995 |
FR |
80 | 2 |
Demyelination, Neurotoxicity, Gait disturbance, Neuropathy peripheral, |
||||
ABEMACICLIB, |
||||
| 59 | 25137119 |
US |
56 | 2 |
Knee arthroplasty, Diarrhoea, Vitamin C deficiency, Gait disturbance, Arthralgia, Feeding disorder, Insomnia, |
||||
UPADACITINIB, |
||||
| 60 | 25126348 |
US |
2 | |
Gait disturbance, Pain in extremity, Burning sensation, Fall, |
||||
DENOSUMAB, |
||||
| 61 | 25126360 |
US |
61 | 1 |
Arterial occlusive disease, Arthritis, Gait disturbance, |
||||
ADALIMUMAB, ADALIMUMAB, METHYLPREDNISOLONE, RIVAROXABAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 62 | 25126559 |
CA |
||
Amnesia, Adjustment disorder with depressed mood, Anxiety, Asthenia, Blood cholesterol increased, Breast cancer stage II, Decreased appetite, Delirium, Depression, Dislocation of vertebra, Dry mouth, Dyspepsia, Facet joint syndrome, Fibromyalgia, Gait disturbance, General physical health deterioration, Grip strength decreased, Headache, Hypertension, Hypoaesthesia, Ill-defined disorder, Inflammation, Injury, Lip dry, Liver disorder, Liver injury, Lung disorder, Malaise, Memory impairment, Migraine, Muscle spasms, Muscular weakness, Musculoskeletal pain, Night sweats, Obesity, Osteoarthritis, Paraesthesia, Peripheral venous disease, Psoriatic arthropathy, Rheumatic fever, Sciatica, Sleep disorder, Swollen joint count increased, Type 2 diabetes mellitus, Weight decreased, X-ray abnormal, Lupus vulgaris, Wound infection, Medication error, Product use issue, Intentional product use issue, Prescribed overdose, Product use in unapproved indication, Off label use, Intentional product use issue, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TOCILIZUMAB, TOCILIZUMAB, |
||||
| 63 | 25127002 |
US |
66 | |
Bone pain, Joint swelling, Gait disturbance, Pain in extremity, Arthralgia, Back pain, |
||||
EVOLOCUMAB, |
||||
| 64 | 25127023 |
US |
75 | 2 |
Fall, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, DULOXETINE HYDROCHLORIDE, CARBIDOPA LEVODOPA, ROPINIROLE, INSULIN DEGLUDEC, HUMAN INSULIN, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, |
||||
| 65 | 25127525 |
CA |
62 | |
Malaise, Wheezing, Pulmonary function test abnormal, Lung adenocarcinoma stage IV, Seizure, Pneumothorax, Exercise tolerance decreased, Drug dependence, Loss of personal independence in daily activities, Full blood count abnormal, Dyspnoea, Chronic obstructive pulmonary disease, Chest discomfort, Bronchitis, Asthma, Therapeutic product effect incomplete, Bone pain, Craniotomy, Gait disturbance, Heart rate increased, Illness, Joint swelling, Metastases to central nervous system, Sleep disorder due to a general medical condition, Steroid dependence, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, BUDESONIDE, BUDESONIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RISEDRONATE SODIUM, ALBUTEROL SULFATE, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 66 | 25127692 |
US |
2 | |
Gait disturbance, Pain in extremity, Burning sensation, Fall, |
||||
DENOSUMAB, |
||||
| 67 | 25128095 |
US |
2 | |
Botulism, Paralysis, Gait disturbance, |
||||
ONABOTULINUMTOXINA, |
||||
| 68 | 25128262 |
US |
56 | 2 |
Hypersensitivity, Pain in extremity, Gait disturbance, Arthralgia, Musculoskeletal pain, Paraesthesia, Back pain, Limb discomfort, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 69 | 25128285 |
US |
2 | |
Visual impairment, Gait disturbance, Multiple sclerosis, Dizziness, Fatigue, Hypoaesthesia, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
| 70 | 25128556 |
US |
1 | |
Gait disturbance, |
||||
EMPAGLIFLOZIN, |
||||
| 71 | 25128778 |
US |
76 | 1 |
Swelling, Gait disturbance, |
||||
RIPRETINIB, |
||||
| 72 | 25128894 |
US |
67 | 2 |
Pain in extremity, Gait disturbance, Peripheral swelling, Peroneal nerve palsy, |
||||
DUPILUMAB, |
||||
| 73 | 25129041 |
US |
78 | 1 |
Chondropathy, Urinary tract infection, Enterococcal infection, Citrobacter infection, Arthralgia, Gait disturbance, Fall, Muscular weakness, Physical deconditioning, |
||||
ABEMACICLIB, ABIRATERONE ACETATE, ABIRATERONE, ABIRATERONE ACETATE, ABIRATERONE, PREDNISONE, PREDNISONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CELECOXIB, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, ATORVASTATIN CALCIUM, POLYETHYLENE GLYCOL 3350, RISPERIDONE, TEMAZEPAM, |
||||
| 74 | 25129101 |
US |
56 | 1 |
Gout, Pain in extremity, Psychomotor hyperactivity, Peripheral swelling, Drug ineffective, Gait disturbance, Pain in extremity, |
||||
| 75 | 25129897 |
CA |
80 | 2 |
Renal failure, Pneumonia, Gait disturbance, Joint swelling, Feeling abnormal, |
||||
RISANKIZUMAB-RZAA, |
||||
| 76 | 25129939 |
US |
2 | |
Catatonia, Confusional state, Gait disturbance, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
| 77 | 25129976 |
US |
86 | 2 |
Cardiac disorder, Gait disturbance, Heart rate decreased, |
||||
ABATACEPT, |
||||
| 78 | 25130057 |
BR |
80 | 2 |
Fall, Femur fracture, Gait disturbance, Erysipelas, Hypersensitivity, Skin exfoliation, Dry skin, Erythema, Joint swelling, Memory impairment, |
||||
RIBOCICLIB, RIBOCICLIB, |
||||
| 79 | 25130307 |
US |
74 | 2 |
Arthropathy, Gait disturbance, Joint swelling, Peripheral swelling, Asthenia, Off label use, Abdominal pain upper, |
||||
AMLODIPINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 80 | 25130312 |
US |
67 | 2 |
Gait disturbance, Pain in extremity, Tendonitis, |
||||
BEMPEDOIC ACID AND EZETIMIBE, BEMPEDOIC ACID AND EZETIMIBE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 81 | 25130734 |
US |
60 | 2 |
Rheumatoid arthritis, Gait disturbance, Product dose omission issue, |
||||
ABATACEPT, |
||||
| 82 | 25130787 |
CA |
||
Psoriasis, Pruritus, Contusion, Subcutaneous drug absorption impaired, Confusional state, Infusion related reaction, Blood cholesterol increased, Abdominal discomfort, Back disorder, Peripheral swelling, Depression, Glossodynia, Musculoskeletal stiffness, Folliculitis, Pyrexia, Muscle injury, Chest pain, Pustular psoriasis, Adjustment disorder with depressed mood, Oedema, Duodenal ulcer perforation, Injury, Myositis, Malaise, Fibromyalgia, Joint swelling, Gait disturbance, Pulmonary fibrosis, Impaired healing, Blister, Dislocation of vertebra, Gait inability, Fatigue, Anti-cyclic citrullinated peptide antibody positive, Breast cancer stage II, Amnesia, Mobility decreased, Rheumatoid arthritis, Lower respiratory tract infection, Sleep disorder, Delirium, Systemic lupus erythematosus, Rheumatoid factor positive, General symptom, Weight increased, Decreased appetite, Hypoaesthesia, Pneumonia, Abdominal pain upper, Sleep disorder due to general medical condition, insomnia type, Swollen joint count increased, Joint range of motion decreased, Hand deformity, Grip strength decreased, Swelling, X-ray abnormal, Dyspepsia, Weight decreased, Type 2 diabetes mellitus, Disability, Hepatic enzyme increased, Pemphigus, Condition aggravated, Dyspnoea, Urticaria, Hypertension, Gastrointestinal disorder, Wound, Arthropathy, Liver injury, Stomatitis, Fluid retention, Arthralgia, Hypercholesterolaemia, Discomfort, Migraine, General physical health deterioration, Ill-defined disorder, Psoriatic arthropathy, Wheezing, Pain in extremity, Rheumatic fever, Memory impairment, Rash vesicular, Alopecia, Nasopharyngitis, Diarrhoea, Nausea, Wound infection, Vomiting, Headache, Hypersensitivity, Helicobacter infection, Infection, Irritable bowel syndrome, Synovitis, Sinusitis, Pericarditis, Pain, Rash, Drug hypersensitivity, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ALENDRONATE SODIUM, CALCIUM CARBONATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, VEDOLIZUMAB, CERTOLIZUMAB PEGOL, ADALIMUMAB, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, INFLIXIMAB, INFLIXIMAB, ADALIMUMAB, GOLIMUMAB, PHENYLEPHRINE HYDROCHLORIDE, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, USTEKINUMAB, GOLIMUMAB, OXYCODONE HYDROCHLORIDE, OXYCODONE, FOLIC ACID, FOLIC ACID, FOLIC ACID, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, VITAMIN C, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, PREDNISONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, APREMILAST, RITUXIMAB, LORAZEPAM, CAFFEINE CITRATE, CALCIUM GLUCONATE, SECUKINUMAB, SECUKINUMAB, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 83 | 25130943 |
US |
43 | 2 |
Coeliac disease, Pharyngitis streptococcal, Muscle spasms, Gait disturbance, Dysmenorrhoea, Off label use, |
||||
PREDNISONE, |
||||
| 84 | 25131215 |
US |
90 | 2 |
Somnolence, Hyperhidrosis, Gait disturbance, Fall, Insomnia, Intentional product use issue, Product use in unapproved indication, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 85 | 25131233 |
GR |
71 | 2 |
Joint arthroplasty, Swelling, Gait disturbance, Wheelchair user, Inflammation, |
||||
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, PREGABALIN, PREGABALIN, METHOTREXATE SODIUM, METHOTREXATE SODIUM, |
||||
| 86 | 25131274 |
CA |
53 | 1 |
Angina pectoris, Blood urine present, Cough, Disturbance in attention, Gait disturbance, Loss of control of legs, Pain in extremity, |
||||
CANDESARTAN CILEXETIL, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, PRAVASTATIN SODIUM, TICAGRELOR, ROSUVASTATIN, ASCORBIC ACID, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, RAMIPRIL, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, IRBESARTAN, |
||||
| 87 | 25131468 |
US |
2 | |
Hysterectomy, Peripheral swelling, Neuropathy peripheral, Impatience, Nail disorder, Skin disorder, Gait disturbance, Unevaluable event, Walking aid user, Hypoaesthesia, Condition aggravated, |
||||
RISANKIZUMAB-RZAA, |
||||
| 88 | 25131541 |
CA |
86 | 1 |
Fall, Gait disturbance, Nystagmus, Tremor, Toxicity to various agents, Drug interaction, |
||||
PHENYTOIN, TRAZODONE HYDROCHLORIDE, |
||||
| 89 | 25131577 |
US |
64 | 1 |
Blindness, Gait disturbance, |
||||
INSULIN GLARGINE, |
||||
| 90 | 25131784 |
PL |
6 | 2 |
Status epilepticus, COVID-19, Respiratory syncytial virus infection, Gait disturbance, Off label use, |
||||
LACOSAMIDE, CLOBAZAM, TOPIRAMATE, TOPIRAMATE SPINKLE, STIRIPENTOL, |
||||
| 91 | 25131870 |
US |
70 | 2 |
COVID-19, Swollen tongue, Muscular weakness, Skin haemorrhage, Joint swelling, Blister rupture, Peripheral swelling, Heart rate irregular, Gait disturbance, Muscle spasms, Skin discolouration, Blister, Rash vesicular, Dizziness, Headache, Arthralgia, Somnolence, Paraesthesia, Rash, Myalgia, Dyspnoea, |
||||
LOSARTAN POTASSIUM, LOSARTAN, CLONIDINE HYDROCHLORIDE, CLONIDINE, LEVOTHYROXINE SODIUM, |
||||
| 92 | 25134491 |
20 | 1 | |
Drooling, Gait disturbance, Gait inability, Dysphagia, Dyspnoea, Unresponsive to stimuli, Swelling face, Flushing, Erythema, Rash, Musculoskeletal stiffness, Hypersensitivity, Confusional state, Muscle rigidity, Feeding disorder, Grip strength decreased, Neuroleptic malignant syndrome, |
||||
RISPERIDONE, CHLORPROMAZINE, DIVALPROEX SODIUM, |
||||
| 93 | 25135674 |
2 | ||
Cerebrovascular accident, Dizziness, Migraine, Gait disturbance, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 94 | 25135867 |
42 | 1 | |
Epididymitis, Gait disturbance, |
||||
SEMAGLUTIDE, LEVOTHYROXINE, |
||||
| 95 | 25121062 |
US |
2 | |
Cough, Asthenia, Blood pressure abnormal, Dyspnoea, Muscular weakness, Gait disturbance, Productive cough, Dizziness, Headache, Nausea, Back pain, Abdominal pain upper, Constipation, Dyspnoea exertional, Muscle spasms, Brain fog, Irritability, Balance disorder, Memory impairment, Myalgia, Immunoglobulins increased, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, NINTEDANIB, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, |
||||
| 96 | 25121153 |
US |
2 | |
Fatigue, Blood cholesterol increased, Decreased appetite, Blood glucose increased, Tremor, Hyperhidrosis, Chills, Hot flush, Bone pain, Headache, Gait disturbance, |
||||
ROSUVASTATIN, ANASTROZOLE, ANASTROZOLE TABLETS, PALBOCICLIB, |
||||
| 97 | 25121172 |
US |
||
Groin pain, Pain in extremity, Arthritis, Bursitis, Gait disturbance, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 98 | 25121954 |
CA |
2 | |
Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Stomatitis, Swelling, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CLONIDINE HYDROCHLORIDE, CLONIDINE, CALCIUM CARBONATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE ACETATE, CHLORHEXIDINE ACETATE, CHLORHEXIDINE ACETATE, CHLORHEXIDINE ACETATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, AZATHIOPRINE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MORPHINE SULFATE, MESALAMINE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, OXYCODONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREGABALIN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, SULFASALAZINE, SULFASALAZINE, SODIUM FLUORIDE, SODIUM FLUORIDE F 18, SODIUM FLUORIDE F-18, TOOTHPASTE, SODIUM FLUORIDE F18, CLEAR MINT, GEL TOOTHPASTE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 99 | 25121989 |
US |
2 | |
Gait disturbance, Muscle spasms, Arthralgia, |
||||
IBANDRONATE SODIUM, |
||||
| 100 | 25121995 |
US |
1 | |
Hallucination, Tremor, Delusion, Loss of personal independence in daily activities, Wheelchair user, Abnormal behaviour, Dysstasia, Gait disturbance, Wrong technique in product usage process, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIPHENHYDRAMINE HYDROCHLORIDE, CARBIDOPA AND LEVODOPA, ENTACAPONE, VIBEGRON, GLIMEPIRIDE, EMPAGLIFLOZIN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, METOPROLOL TARTRATE, METOPROLOL, TEMAZEPAM, TRAVOPROST, TRAVOPROST (ISOMER FREE), ERGOCALCIFEROL, BREXPIPRAZOLE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28